TARSUS PHARMACEUTICALS, INC. (TARS) Shareholders’ equity 2020–2025
TARSUS PHARMACEUTICALS, INC. (TARS) shareholders’ equity at each fiscal year-end, per SEC filings.
$343.4MFY2025 · since FY2020: $166.0M → $343.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $343.4M | +53.0% |
| FY2024 | $224.5M | +14.0% |
| FY2023 | $197.0M | +2.1% |
| FY2022 | $192.9M | +15.7% |
| FY2021 | $166.7M | +0.5% |
| FY2020 | $166.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice